A lot going on in the clinical trials arena. I don't want to report in full until some things are settled. I'm not certain that some things aren't proprietary, and in other cases I know there's the medical equivalent of business confidentiality in play. Also, while I have a lot of comments on process, I don't want to articulate them in the middle of everything either.
Suffice to say there are several good options presently on the table, and I will probably know by the beginning of next week what my next steps are. Which will be nice, because then I can start fitting the rest of my on-hold life plans into place around the clinical trial milestones.